
Telque AMH 40mg/5mg/12.5mg Tablet
Marketer
Tms India Pvt Ltd
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Telque AMH 40mg/5mg/12.5mg Tablet
Amlodipine/Hydrochlorothiazide/Valsartan 40mg/5mg/12.5mg tablets are a triple-drug formulation indicated for managing hypertension when monotherapy proves insufficient. This medication reduces elevated blood pressure, consequently lowering the risk of future cardiovascular events like stroke and myocardial infarction. Administration is independent of food intake; however, consistent daily timing is recommended. Dosage is individualized based on patient response and overall health. Continuous use, as directed by your physician, is crucial; premature discontinuation increases stroke and heart attack risk. The formulation incorporates a diuretic, potentially increasing urination, thus evening administration is advised to minimize nighttime bathroom trips. Regular use maximizes therapeutic benefits, even during periods of asymptomatic blood pressure. Common side effects may include fatigue, headache, dizziness, altered taste perception, flu-like symptoms, diarrhea, and sinus inflammation. Report persistent, worsening, or bothersome side effects to your doctor immediately. Maintain adequate hydration to mitigate potential side effects such as dry mouth, thirst, and muscle weakness. Prior to initiation, inform your doctor of pre-existing liver or kidney disease, pregnancy, breastfeeding, or any other medications, particularly those impacting blood pressure or cardiac function. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is essential to assess therapeutic efficacy and safety.
Uses of Telque AMH 40mg/5mg/12.5mg Tablet
Elevated arterial blood pressure
Major Benefits of Telque AMH 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Telque AMH 40mg/5mg/12.5mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently; however, consistent timing is recommended.
Common Side effects of Telque AMH 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Telque AMH 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telque AMH 40mg/5mg/12.5mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Telque AMH 40mg/5mg/12.5mg Tablet works:
Each Telque AMH 40mg/5mg/12.5mg tablet unites telmisartan, amlodipine, and hydrochlorothiazide—three distinct agents. Telmisartan, an angiotensin receptor blocker (ARB), and amlodipine, a calcium channel blocker (CCB), collaboratively dilate blood vessels, thus reducing blood pressure. Hydrochlorothiazide, a diuretic, promotes fluid excretion via the kidneys, alongside a gradual vasodilatory effect and enhanced circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Telque AMH 40mg/5mg/12.5mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Use of Telque AMH 40mg/5mg/12.5mg tablets is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Breastfeeding mothers should avoid Telque AMH 40mg/5mg/12.5mg Tablets. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects of Telque AMH 40mg/5mg/12.5mg Tablets. These potential side effects include dizziness, headaches, nausea, and fatigue, all of which can compromise concentration and safe driving.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telque AMH 40mg/5mg/12.5mg tablets, as dose modification may be necessary. Physician consultation is advised. Telque AMH 40mg/5mg/12.5mg tablets are not recommended for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Telque AMH 40mg/5mg/12.5mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Telque AMH 40mg/5mg/12.5mg Tablet :
Should you forget a Telque AMH 40mg/5mg/12.5mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telque AMH 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
